Salvatore Fiorenza

9PUBLICATIONS
33CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 29, 2025
Associations Between the Gut Microbiome and Outcomes in Autologous Stem Cell Transplantation: A Systematic Review.

Ema Pitts, Brian Grainger, Dean McKenzie

|Feb 18, 2025
Outcome correlates of approved CD19-targeted CAR T cells for large B cell lymphoma.

Tamara J Bock, Chanukya K Colonne, Salvatore Fiorenza

|Feb 10, 2025
Protection of CD33-modified hematopoietic stem cell progeny from CD33-directed CAR T cells in rhesus macaques.

Nicholas E Petty, Stefan Radtke, Greta Kanestrom

|Sep 27, 2024
Histone marks identify novel transcription factors that parse CAR-T subset-of-origin, clinical potential and expansion.

S Fiorenza, Y Zheng, J Purushe

|Sep 14, 2024
Safety and Efficacy of Bispecific Antibodies in Adults with Large B-Cell Lymphomas: A Systematic Review of Clinical Trial Data.

Elena Bayly-McCredie, Maxine Treisman, Salvatore Fiorenza

|Oct 30, 2023
Timing of anti-PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma.

Alexandre V Hirayama, Erik L Kimble, Jocelyn H Wright

Pageof 2

Frequent Collaborators

4 joint publications

Cameron J Turtle

3 joint publications

Alexandre V Hirayama

2 joint publications

Tamara J Bock

2 joint publications

Erik L Kimble